Back to Journals » Cancer Management and Research » Volume 12

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway

Total article views   HTML views PDF downloads Totals
8,346 Dovepress* 7,699+ 998 8,697
PubMed Central* 647 254 901
Totals 8,346 1,252 9,598
*Since 19 May 2020
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar